Satellos Bioscience Inc. (TSX:MSCL)
Canada · Delayed Price · Currency is CAD 8.00
-0.02 (-0.25%)
Jun 15, 2026, 3:59 PM EST
Satellos Bioscience Market Cap
Satellos Bioscience has a market cap or net worth of CAD 167.07 million as of June 16, 2026. Its market cap has increased by 45.78% in one year.
Market Cap
167.07M
Enterprise Value
69.48M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
8.00
Market Cap Chart
Since August 19, 2021, Satellos Bioscience's market cap has increased from 58.83M to 167.07M, an increase of 183.97%. That is a compound annual growth rate of 24.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 166.65M | 36.11% |
| Dec 31, 2025 | 122.43M | -11.04% |
| Dec 31, 2024 | 137.63M | 183.77% |
| Dec 29, 2023 | 48.50M | 427.44% |
| Dec 30, 2022 | 9.20M | -72.13% |
| Dec 31, 2021 | 33.00M | -43.91% |
| Aug 19, 2021 | 58.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 552.01M |
| Helix BioPharma | 120.68M |
| Telescope Innovations | 68.68M |
| Sharp Therapeutics | 63.16M |
| ME Therapeutics Holdings | 59.80M |
| Sernova Biotherapeutics | 54.67M |
| NurExone Biologic | 47.86M |
| MedMira | 45.61M |